Grifols, S.A. (ADR)
General ticker "GIKLY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $14.4B (TTM average)
Grifols, S.A. (ADR) follows the US Stock Market performance with the rate: 39.1%.
Estimated limits based on current volatility of 0.2%: low 6.42$, high 6.45$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-08-12, amount 0.09$ (Y1.40%)
- Total employees count: 157 as of 2010
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.17$, 10.54$]
- 2025-12-31 to 2026-12-31 estimated range: [7.67$, 12.50$]
Financial Metrics affecting the GIKLY estimates:
- Positive: with PPE of 39.7 at the end of fiscal year the price was very low
- Positive: Operating cash flow per share per price, % of 14.19 > 12.96
- Positive: 7.67 < Operating profit margin, % of 16.53
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of 0.73
- Positive: 19.40 < Shareholder equity ratio, % of 27.49 <= 42.68
- Negative: Industry operating cash flow per share per price (median), % of 8.11 <= 10.29
- Positive: Industry earnings per price (median), % of 5.35 > 4.49
Short-term GIKLY quotes
Long-term GIKLY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €6,063.97MM | €6,591.98MM | €7,212.38MM |
| Operating Expenses | €5,281.53MM | €5,792.58MM | €6,020.37MM |
| Operating Income | €782.44MM | €799.40MM | €1,192.02MM |
| Non-Operating Income | €-444.42MM | €-575.38MM | €-748.02MM |
| Interest Expense | €444.54MM | €516.06MM | €773.15MM |
| R&D Expense | €361.14MM | €395.28MM | €384.04MM |
| Income(Loss) | €338.01MM | €224.02MM | €444.00MM |
| Taxes | €90.11MM | €43.35MM | €231.19MM |
| Profit(Loss)* | €208.28MM | €59.31MM | €156.92MM |
| Stockholders Equity | €6,129.94MM | €5,827.17MM | €5,883.73MM |
| Inventory | €3,236.01MM | €3,459.28MM | €3,560.10MM |
| Assets | €21,533.98MM | €21,441.05MM | €21,405.24MM |
| Operating Cash Flow | €-10.87MM | €208.28MM | €902.17MM |
| Capital expenditure | €375.56MM | €295.42MM | €371.37MM |
| Investing Cash Flow | €-1,978.82MM | €-397.64MM | €886.67MM |
| Financing Cash Flow | €-173.49MM | €186.04MM | €-1,358.71MM |
| Earnings Per Share** | €0.15 | €0.04 | €0.12 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.